Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
Completed · Phase 3
Conditions studied: Complicated Skin and Soft Tissue Infection
In brief
The purpose of this study is to evaluate the effects of Ceftaroline Fosamil versus Vancomycin plus Aztreonam in treatment of patients with complicated bacterial skin and soft tissue infections.
Key facts
- Study ID
- NCT01499277
- Run by
- Pfizer
- People needed
- 802
- Starts
- 2012-05-01
- Expected to finish
- 2015-01-01
- Last updated by the study team
- 2017-09-06
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female, aged 18 years or older
- Complicated skin and skin structure infection (cSSTI)
- Infection of sufficient severity to warrant hospitalization
- Infection of sufficient severity such that it is expected to require at least 5 days of intravenous antibiotic therapy
You may not qualify if…
- Received systemic antibacterial drugs for greater than 24 hours within 96 hours prior to first dose of study drug
- Uncomplicated skin and skin structure infections, skin infections suspected to be caused by viral or fungal pathogens
- Diabetic foot infections, decubitus ulcers, ulcers due to peripheral vascular disease
- Infection caused by human or animal bites, sternal wound infections, bone infection or arthritis due to an infection, critical limb ischemia of the affected limb
- Chronic liver disease or severe impaired renal function, severe low white blood cell count, burns on greater than 15% of total body surface area, necrotizing skin infection, amputation required of primary site of infection, sustained shock
Where it is running
- Research Site — Orlando, Florida, United States
- Research Site — West Palm Beach, Florida, United States
- Research Site — Carmel, Indiana, United States
- Research Site — Hazard, Kentucky, United States
- Research Site — Springfield, Massachusetts, United States
- Research Site — Detroit, Michigan, United States
- Research Site — Las Vegas, Nevada, United States
- Research Site — Garden City, New York, United States
- Research Site — Bellaire, Texas, United States
- Research Site — Córdoba, Argentina
- Research Site — Santa Fe, Argentina
- Research Site — Parkville, Australia
- Research Site — Brussels, Belgium
- Research Site — Belo Horizonte, Brazil
- Research Site — Passo Fundo, Brazil
- Research Site — Salvador, Brazil
- Research Site — São José do Rio Preto, Brazil
- Research Site — Pleven, Bulgaria
- Research Site — Rousse, Bulgaria
- Research Site — Sofia, Bulgaria
- Research Site — Temuco, Chile
- Research Site — Viña del Mar, Chile
- Research Site — Beijing, China
- Research Site — Changchun, China
- Research Site — Chula Vista, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.